- Conditions
- Cardiovascular Diseases (CVD), Dietary Fiber, Gastrointestinal Microbiome, Insulin Resistance, Inulin, Microbiota, Muscle, Skeletal, Obesity & Overweight, Perimenopausal Women, Prebiotics, Vascular Health, Women Health
- Interventions
- Inulin, Maltodextrin (Placebo)
- Dietary Supplement
- Lead sponsor
- George Washington University
- Other
- Eligibility
- 40 Years to 55 Years · Female only
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 169–192
of 680
matching trials from the local directory fallback.
- Conditions
- Aneurysmal Subarachnoid Hemorrhage, Endovascular Treatment, Transcutaneous Vagal Nerve Stimulation (tVNS), Vasospasm, Cerebral
- Interventions
- Transcutaneous Vagal Nerve Stimulation
- Device
- Lead sponsor
- Marshall Holland
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Cardio Vascular Disease, Cardiogenic Pulmonary Oedema, Cardiogenic Shock, Cardiopulmonary, Critical Illness, Mechanical Ventilation, Respiration Failure
- Interventions
- Pressure Controlled Mode, Volume Controlled Mode
- Other
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Cardiovascular Health, Cognitive Health, DHA and EPA Blood Levels, Omega-3 Deficiency
- Interventions
- Omega Active Supplement
- Dietary Supplement
- Lead sponsor
- Revive Active
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 49 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Las Vegas, Nevada
- Conditions
- Adiposity, Cardiometabolic Syndrome, Cardiovascular Diseases
- Interventions
- Chardonnay Marc
- Other
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 45 Years to 70 Years · Female only
- Enrollment
- 5 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Davis, California
- Conditions
- Cardiovascular, Cardiovascular Disease, Chronic Kidney Diease, Chronic Obstructive Pulmonary Disease (COPD), Comorbidity, Diabetes, Inflammatory Joint Diseases
- Interventions
- Not listed
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 50 Years to 99 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Age-Related Macular Degeneration, Choroidal Neovascularization, Macular Degeneration, Wet Macular Degeneration
- Interventions
- Aflibercept, Tiespectus
- Drug
- Lead sponsor
- EyeBiotech Ltd.
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 960 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 52
- States / cities
- Gilbert, Arizona • Encino, California • Mountain View, California + 49 more
- Conditions
- Brain Disease, Endothelial Dysfunction, Kidney Injury, Vascular Diseases, Vascular Inflammation
- Interventions
- Placebo, Vericiguat
- Drug
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 170 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2029
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
- Interventions
- Ixo-vec
- Genetic
- Lead sponsor
- Adverum Biotechnologies, Inc.
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 12
- States / cities
- Phoenix, Arizona • Bakersfield, California • Fullerton, California + 8 more
- Conditions
- Cardiovascular Events, Community-acquired Pneumonia, Influenza
- Interventions
- Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4), High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
- Biological
- Lead sponsor
- Kaiser Permanente
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 1,500,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2028
- U.S. locations
- 1
- States / cities
- Oakland, California
- Conditions
- Cardiovascular Risk Factor, Sleep
- Interventions
- Regularized Sleep Schedule
- Behavioral
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 25 Years to 65 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, Atypical Fibroxanthoma, Clear Cell Sarcoma, Dedifferentiated Liposarcoma, Dermatofibrosarcoma Protuberans, Fibrosarcomatous, Epithelioid Hemangioendothelioma, Epithelioid Sarcoma, Extraskeletal Myxoid Chondrosarcoma, Fibrosarcoma NOS, Giant Cell Tumor of Soft Parts NOS, Glomus Tumor, Granular Cell Tumor, Malignant, Inflammatory Leiomyosarcoma, Intimal Sarcoma, Leiomyosarcoma, Liposarcoma, Low Grade Fibromyxoid Sarcoma, Low Grade Myofibroblastic Sarcoma, Malignant Peripheral Nerve Sheath Tumor, Malignant Tenosynovial Giant Cell Tumor of Soft Tissue, Melanotic Malignant Nerve Sheath Tumor, Myoepithelial Carcinoma, Myoepithelioma, Myxofibrosarcoma, Myxoid Liposarcoma, Myxoid Pleomorphic Liposarcoma, NTRK-Rearranged Spindle Cell Neoplasm, Ossifying Fibromyxoid Tumor, Malignant, Osteosarcoma, Extraskeletal, Perineurioma, Malignant, Perivascular Epithelioid Tumor, Malignant, Phosphaturic Mesenchymal Tumor, Malignant, Pleomorphic Liposarcoma, Pleomorphic Sarcoma, Undifferentiated, Round Cell Sarcoma, Round Cell Sarcoma, Undifferentiated, Sclerosing Epithelioid Fibrosarcoma, Synovial Sarcoma, Undifferentiated Sarcoma, Well Differentiated Liposarcoma
- Interventions
- Doxorubicin, Ifosfamide, Pazopanib, Proton beam radiation therapy, Selinexor, Surgical resection
- Drug · Radiation · Procedure
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Eligibility
- Up to 30 Years
- Enrollment
- 139 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2037
- U.S. locations
- 7
- States / cities
- Atlanta, Georgia • Chicago, Illinois • Baton Rouge, Louisiana + 4 more
- Conditions
- Aortic Diseases, Atrial Fibrillation, Cardiovascular Diseases, Congenital Heart Disease, Heart Failure, Ischemic Heart Disease, Metabolic Cardiomyopathy, Non-ischemic Cardiomyopathy, Valvular Heart Disease, Ventricular Fibrillation
- Interventions
- Not listed
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2037
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Cardiovascular Diseases, Cardiovascular Risk Factors
- Interventions
- Not listed
- Lead sponsor
- University of Oxford
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 250,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2030
- U.S. locations
- 12
- States / cities
- Phoenix, Arizona • New Haven, Connecticut • Tampa, Florida + 8 more
- Conditions
- Gestational Diabetes, Vascular Endothelial Function
- Interventions
- Acetylcholine, insulin aspart
- Drug
- Lead sponsor
- Anna Stanhewicz, PhD
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 28 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2027
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Energy Expenditure, Insulin Sensitivity/Resistance, Metabolic Disease, Metabolism, Natriuretic Peptides
- Interventions
- Exercise capacity VO2 maximum determination, Intravenous Glucose Tolerance Test, Sacubitril, Valsartan 97-103 mg Oral Tablet, Standardized Meals, Valsartan 160 mg
- Other · Drug · Dietary Supplement
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2027
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Anxiety, Cardiovascular Diseases, Caregiver Burden, Depression, Stress
- Interventions
- Confident Caregiver Intervention
- Behavioral
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Sacramento, California
- Conditions
- Cardiovascular Diseases, Depression
- Interventions
- BA-HT, Standard Care
- Behavioral · Other
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 21 Years and older
- Enrollment
- 132 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
- Conditions
- Cardiovascular Diseases
- Interventions
- d-Coaching
- Behavioral
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 21 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 2
- States / cities
- San Francisco, California • Decatur, Georgia
- Conditions
- Cardiovascular Disease Risk Factor, Obese Adolescents, Obesity and Overweight, Weight Loss, Weight Management
- Interventions
- Ozempic®
- Drug
- Lead sponsor
- John Bauer
- Other
- Eligibility
- 12 Years to 17 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Cardiovascular Conditions After Birth, Neurological Diseases or Conditions, Psychophysiologic Disorders
- Interventions
- Active CR
- Device
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 11 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2028
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Cardiovascular Diseases, Obesity
- Interventions
- PREVENT Tool, Wait-List Control
- Behavioral
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Arteriovenous Malformations, Cerebral Arteriovenous Malformations, Epistaxis, GastroIntestinal Bleeding, Hereditary Hemorrhagic Telangiectasia, Telangiectasia, Vascular Malformation
- Interventions
- Not listed
- Lead sponsor
- Cure HHT
- Other
- Eligibility
- Not listed
- Enrollment
- 10,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2033
- U.S. locations
- 16
- States / cities
- Birmingham, Alabama • Los Angeles, California • San Francisco, California + 13 more
- Conditions
- Cardiovascular, Tumor
- Interventions
- Not listed
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Houston, Texas